Peter Langer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peter Langer has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
M. Rothmund
4 shared publications- Bruno Allolio
Department of Internal Medicine I (B.A.), University Hospital, University of Würzburg, 97070 Würzburg, Germany
2 shared publications - D. Weismann
Universitätsklinikum Würzburg
2 shared publications - E. P. Slater
Department of Surgery
2 shared publications M Rothmund
Department of General Surgery, Philipps-University Marburg, Germany
2 shared publications- Martin Fassnacht
Comprehensive Cancer Center Mainfranken (M.F.), University of Würzburg, 97252 Würzburg, Germany 10 and Department of Internal Medicine (M.F.), Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, 80337 Munich, Germany
2 shared publications
Latest Publications
- 11 August 2014
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 52 (08) , KC015
Multiple kleine Seitgang-IPMN Indikatoren in der Bildgebung beim familiären Pankreaskarzinom – Indikator für vorhandene höhergradige PanIN-Läsionen im Pankreas?
Hintergrund: Screeningprogramme für das familiäre Pankreaskarzinom (FPC) basieren auf endosonographischer und/oder MR-tomographischer Bildgebung. Bei bis zu 40% der Risikopersonen (RP) werden hierbei zystische Läsionen detektiert, die verdächtig auf kleine intraduktale papilläre muzinösen Neoplasien der Seitengänge (BD-IPMN) sind. Die pathologische Bedeutung dieser Läsionen beim FPC ist bisher nicht geklärt. Patienten und Methoden: RP des prospektiven Screeningprogramms der Nationalen Fallsammlung familiäres Pankreaskarzinom mit kleinen „Imaging“ -IPMNs, die sich einer Operation unterzogen, wurden hinsichtlich der klinisch-pathologischen Ergebnisse und der Lokalisation der Läsionen analysiert. Ergebnisse: In 11 Jahren (2002 – 2013) nahmen 180 RP aus 81 FPC-Familien am Screeningprogramm teil. 84 RP (46%) wiesen kleine zystische (2 – 10 mm) unizystische Läsionen oder multizystische Läsionen im Pankreas auf, welche MR-tomographisch verdächtig auf BD-IPMN waren. Bei 7 dieser RP mit multiplen Läsionen (> 3) wurde nach interdisziplinärer Besprechung eine Pankreasresektion (6 totale Pankreatektomie, 1 PPPD) durchgeführt, obwohl die Sendai-Kriterien für eine IPMN-Resektion nicht erfüllt waren. Die histologische Aufarbeitung ergab bei 6 dieser Patienten BD-IPMNs mit niedriger bzw. moderater Dysplasie vom gastrischen Typ in Kombination mit multifokalen PanIN2 und PanIN3-Läsionen. Eine Patientin hatte lediglich winzige Gangektasien im Pankreasschwanz mit multifokalen PanIN-II-Läsionen sowie einer PanIN-III-Läsion im Pankreaskopf. Überraschend war, dass die Lokalisation der histologisch gesicherten PanIN2/3-Läsionen nicht mit den präoperativ in der Bildgebung dargestellten zystischen Läsionen korrespondierten und auch retrospektiv nicht sichtbar waren. Schlussfolgerung: Im Rahmen des FPC könnte das Vorliegen von multiplen, kleinen „Imaging“-BD-IPMNs ein Indikator für die Präsenz höhergradiger PanIN-Läsionen an anderen Lokalisation im Pankreas sein.
- 11 August 2014
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 52 (08) , KC015
Multiple kleine Seitgang-IPMN Indikatoren in der Bildgebung beim familiären Pankreaskarzinom – Indikator für vorhandene höhergradige PanIN-Läsionen im Pankreas?
Hintergrund: Screeningprogramme für das familiäre Pankreaskarzinom (FPC) basieren auf endosonographischer und/oder MR-tomographischer Bildgebung. Bei bis zu 40% der Risikopersonen (RP) werden hierbei zystische Läsionen detektiert, die verdächtig auf kleine intraduktale papilläre muzinösen Neoplasien der Seitengänge (BD-IPMN) sind. Die pathologische Bedeutung dieser Läsionen beim FPC ist bisher nicht geklärt. Patienten und Methoden: RP des prospektiven Screeningprogramms der Nationalen Fallsammlung familiäres Pankreaskarzinom mit kleinen „Imaging“ -IPMNs, die sich einer Operation unterzogen, wurden hinsichtlich der klinisch-pathologischen Ergebnisse und der Lokalisation der Läsionen analysiert. Ergebnisse: In 11 Jahren (2002 – 2013) nahmen 180 RP aus 81 FPC-Familien am Screeningprogramm teil. 84 RP (46%) wiesen kleine zystische (2 – 10 mm) unizystische Läsionen oder multizystische Läsionen im Pankreas auf, welche MR-tomographisch verdächtig auf BD-IPMN waren. Bei 7 dieser RP mit multiplen Läsionen (> 3) wurde nach interdisziplinärer Besprechung eine Pankreasresektion (6 totale Pankreatektomie, 1 PPPD) durchgeführt, obwohl die Sendai-Kriterien für eine IPMN-Resektion nicht erfüllt waren. Die histologische Aufarbeitung ergab bei 6 dieser Patienten BD-IPMNs mit niedriger bzw. moderater Dysplasie vom gastrischen Typ in Kombination mit multifokalen PanIN2 und PanIN3-Läsionen. Eine Patientin hatte lediglich winzige Gangektasien im Pankreasschwanz mit multifokalen PanIN-II-Läsionen sowie einer PanIN-III-Läsion im Pankreaskopf. Überraschend war, dass die Lokalisation der histologisch gesicherten PanIN2/3-Läsionen nicht mit den präoperativ in der Bildgebung dargestellten zystischen Läsionen korrespondierten und auch retrospektiv nicht sichtbar waren. Schlussfolgerung: Im Rahmen des FPC könnte das Vorliegen von multiplen, kleinen „Imaging“-BD-IPMNs ein Indikator für die Präsenz höhergradiger PanIN-Läsionen an anderen Lokalisation im Pankreas sein.
- 5 January 2011
- Published by Springer Nature in Familial Cancer
- Vol. 10 (2) , 323-330
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience
Familial pancreatic cancer (FPC) is a rare hereditary tumor syndrome. The 10-years experience of the national case collection for familial pancreatic cancer of Germany (FaPaCa) is reported. Since 1999 FaPaCa has collected families with at least two first-degree relatives with confirmed pancreatic cancer (PC), who did not fulfill the criteria of other hereditary tumor syndromes. Histopathological verification of tumor diagnoses, and genetic counseling were prerequisites for enrollment of families in FaPaCa. 94 of 452 evaluated families fulfilled the criteria for partaking in FaPaCa. PC represented the sole tumor entity in 38 (40%) families. In 56 families additional tumor types occurred, including breast cancer (n = 28), colon cancer (n = 20) and lung cancer (n = 11). In 70 (74%) families the pattern of inheritance was consistent with an autosomal dominant trait. Compared to the preceding generation, a younger age of onset was observed in the offspring of PC patients (median: 57 vs. 69 years), indicating anticipation. Mutation analyses of BRCA2, PALB2, CDKN2a, RNASEL, STK11, NOD2, CHEK2 and PALLD, revealed deleterious causative germline mutations of BRCA2 and PALB2 in 2 of 70 (3%) and 2 of 41 (4.9%) German FPC families, respectively. Prospective PC screening with EUS, MRI and MRCP detected precancerous lesions (IPMN, multifocal PanIN2/3) or carcinoma in 5.5% (4 of 72) to 12.5% (9 of 72) of individuals at risk, depending on histological verification. Appropriate inclusion of families at high risk for PC in registries, such as FaPaCa, provides a unique and excellent tool to gain clinical and genetic knowledge of FPC. Focused research projects can be conducted most efficiently, when data of different FPC registries are combined.
- 5 January 2011
- Published by Springer Nature in Familial Cancer
- Vol. 10 (2) , 323-330
German national case collection for familial pancreatic cancer (FaPaCa): ten years experience
Familial pancreatic cancer (FPC) is a rare hereditary tumor syndrome. The 10-years experience of the national case collection for familial pancreatic cancer of Germany (FaPaCa) is reported. Since 1999 FaPaCa has collected families with at least two first-degree relatives with confirmed pancreatic cancer (PC), who did not fulfill the criteria of other hereditary tumor syndromes. Histopathological verification of tumor diagnoses, and genetic counseling were prerequisites for enrollment of families in FaPaCa. 94 of 452 evaluated families fulfilled the criteria for partaking in FaPaCa. PC represented the sole tumor entity in 38 (40%) families. In 56 families additional tumor types occurred, including breast cancer (n = 28), colon cancer (n = 20) and lung cancer (n = 11). In 70 (74%) families the pattern of inheritance was consistent with an autosomal dominant trait. Compared to the preceding generation, a younger age of onset was observed in the offspring of PC patients (median: 57 vs. 69 years), indicating anticipation. Mutation analyses of BRCA2, PALB2, CDKN2a, RNASEL, STK11, NOD2, CHEK2 and PALLD, revealed deleterious causative germline mutations of BRCA2 and PALB2 in 2 of 70 (3%) and 2 of 41 (4.9%) German FPC families, respectively. Prospective PC screening with EUS, MRI and MRCP detected precancerous lesions (IPMN, multifocal PanIN2/3) or carcinoma in 5.5% (4 of 72) to 12.5% (9 of 72) of individuals at risk, depending on histological verification. Appropriate inclusion of families at high risk for PC in registries, such as FaPaCa, provides a unique and excellent tool to gain clinical and genetic knowledge of FPC. Focused research projects can be conducted most efficiently, when data of different FPC registries are combined.
- 16 June 2009
- Published by Georg Thieme Verlag KG in TumorDiagnostik & Therapie
- Vol. 30 (03) , 139-143
Multifocal Early Gastric Cancer in a Patient with Autoimmune Atrophic Gastritis and Iron Deficiency Anaemia
Die atrophische Autoimmungastritis (AMAG) ist typischerweise im Magenkorpus lokalisiert und durch den Nachweis von Parietalzellantikörpern (PCA) charakterisiert. Das Auftreten einer perniziösen Anämie wird als Hauptcharakteristikum und typische Begleiterscheinung angesehen und ist in 60 – 90 % der Fälle mit dem Nachweis von PCA assoziiert. AMAG wird als unabhängiger Risikofaktor für die Entstehung eines Magenkarzinoms angesehen. Interessanterweise ist das Fortschreiten von AMAG zur Neoplasie nur bei Patienten mit PA berichtet worden. AMAG kann jedoch auch ohne Koinzidenz von PA auftreten und ist mittlerweile mit anderen hämatologischen Erkrankungen wie der Eisenmangelanämie assoziiert worden. Dies ist der 1. Fallbericht einer Patientin mit AMAG und begleitender Eisenmangelanämie, die 3 Jahre nach der Erstdiagnose ein multifokales Magenfrühkarzinom entwickelt. Zudem zeigt sich ein atypisch morphologisches Verteilungsmuster im Antrum und Magenkorpus. Eine H.-pylori-Infektion als Ursache für die Antrum-Beteiligung konnte wiederholt durch Atemtests, histologische und serologische Untersuchungen (H.-pylori-Antikörper) ausgeschlossen werden. Zusammenfassend zeigt unser Fallbericht, dass die Koinzidenz von AMAG mit einem atypischen Verteilungsmuster und einer Eisenmangelanämie möglicherweise einen Hinweis für ein erhöhtes Magenkrebsrisiko darstellt. Dieses Risiko sollte in Vorsorgestrategien bei AMAG-Patienten einfließen. Autoimmune atrophic gastritis (AMAG) is characterised by the presence of parietal cell antibodies (PCA) and occurs in the gastric corpus. Pernicious anaemia (PA) is regarded as the most distinct feature and sequela of AMAG and is associated with the presence of PCA in about 60 – 90 % of cases. AMAG is considered as an independent risk factor for the development of gastric cancer. Interestingly, the risk to progress from metaplasia to neoplasia and ultimately invasive cancer has exclusively been described in patients with PA. However, AMAG can also occur in the absence of PA, sometimes even in association with other haematological manifestations such as iron deficiency anaemia (IDA). This is the first report of a patient with AMAG associated with IDA and the development of multifocal early gastric cancer only three years after initial diagnosis. Furthermore, our patient showed an atypical morphological distribution pattern of atrophic mucosa with involvement of both the gastric corpus and the antrum. H. pylori infection as a cause for the involvement of the antrum could be repeatedly excluded by breath test, histology and serological testing for H. pylori antibodies. In summary, the presence of IDA together with an atypical distribution pattern of AMAG may represent predictors for the individual risk to progress to gastric cancer and should be taken into account in surveillance strategies.
- 16 June 2009
- Published by Georg Thieme Verlag KG in TumorDiagnostik & Therapie
- Vol. 30 (03) , 139-143
Multifocal Early Gastric Cancer in a Patient with Autoimmune Atrophic Gastritis and Iron Deficiency Anaemia
Die atrophische Autoimmungastritis (AMAG) ist typischerweise im Magenkorpus lokalisiert und durch den Nachweis von Parietalzellantikörpern (PCA) charakterisiert. Das Auftreten einer perniziösen Anämie wird als Hauptcharakteristikum und typische Begleiterscheinung angesehen und ist in 60 – 90 % der Fälle mit dem Nachweis von PCA assoziiert. AMAG wird als unabhängiger Risikofaktor für die Entstehung eines Magenkarzinoms angesehen. Interessanterweise ist das Fortschreiten von AMAG zur Neoplasie nur bei Patienten mit PA berichtet worden. AMAG kann jedoch auch ohne Koinzidenz von PA auftreten und ist mittlerweile mit anderen hämatologischen Erkrankungen wie der Eisenmangelanämie assoziiert worden. Dies ist der 1. Fallbericht einer Patientin mit AMAG und begleitender Eisenmangelanämie, die 3 Jahre nach der Erstdiagnose ein multifokales Magenfrühkarzinom entwickelt. Zudem zeigt sich ein atypisch morphologisches Verteilungsmuster im Antrum und Magenkorpus. Eine H.-pylori-Infektion als Ursache für die Antrum-Beteiligung konnte wiederholt durch Atemtests, histologische und serologische Untersuchungen (H.-pylori-Antikörper) ausgeschlossen werden. Zusammenfassend zeigt unser Fallbericht, dass die Koinzidenz von AMAG mit einem atypischen Verteilungsmuster und einer Eisenmangelanämie möglicherweise einen Hinweis für ein erhöhtes Magenkrebsrisiko darstellt. Dieses Risiko sollte in Vorsorgestrategien bei AMAG-Patienten einfließen. Autoimmune atrophic gastritis (AMAG) is characterised by the presence of parietal cell antibodies (PCA) and occurs in the gastric corpus. Pernicious anaemia (PA) is regarded as the most distinct feature and sequela of AMAG and is associated with the presence of PCA in about 60 – 90 % of cases. AMAG is considered as an independent risk factor for the development of gastric cancer. Interestingly, the risk to progress from metaplasia to neoplasia and ultimately invasive cancer has exclusively been described in patients with PA. However, AMAG can also occur in the absence of PA, sometimes even in association with other haematological manifestations such as iron deficiency anaemia (IDA). This is the first report of a patient with AMAG associated with IDA and the development of multifocal early gastric cancer only three years after initial diagnosis. Furthermore, our patient showed an atypical morphological distribution pattern of atrophic mucosa with involvement of both the gastric corpus and the antrum. H. pylori infection as a cause for the involvement of the antrum could be repeatedly excluded by breath test, histology and serological testing for H. pylori antibodies. In summary, the presence of IDA together with an atypical distribution pattern of AMAG may represent predictors for the individual risk to progress to gastric cancer and should be taken into account in surveillance strategies.
Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer
Objective: Familial pancreatic cancer (FPC) accounts for approximately 3% of all pancreatic cancer (PC) cases. It has been suggested that high-risk individuals (HRIs) should be offered a screening programme. Aim: To evaluate the diagnostic yield of a prospective screening programme in HRIs from families with FPC over a period of 5 years. Methods: HRIs of families with FPC of the National German Familial Pancreatic Cancer Registry (FaPaCa) were counselled and enrolled in a prospective, board-approved PC screening programme. Screening included clinical examination, laboratory tests, endoscopic ultrasound (EUS) and MRI with magnetic resonance cholangiopancreaticography (MRCP) and MR angiography. Results: Between June 2002 and December 2007, 76 HRIs of families with FPC took part in the screening programme with a total of 182 examination visits. Twenty-eight patients revealed abnormalities in EUS (n = 25) and/or MR/MRCP (n = 12). In 7 patients fine needle aspiration cytology was performed. Operative pancreatic explorations were performed in 7 individuals, resulting in limited resections in 6 cases. Histopathological examination of the resected specimens showed serous oligocystic adenomas (n = 3), pancreatic intraepithelial neoplasia 1 (PanIN1) lesions with lobular fibrosis (n = 1), PanIN2 lesions (n = 1) and PanIN1 lesion plus a gastric type intraductal papillary mucinous neoplasm (IPMN) (n = 1). Conclusions: In FPC an EUS/MR/MRCP-based screening programme leads to the detection of potential precursor lesions of PC. However, the yield of an extensive screening programme is low, especially since the tumourigenic value of low grade PanIN lesions is not yet defined. Taking into account the enormous psychological stress for the tested individual and the high costs, a general PC screening in HRIs is not justified.
Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer
Objective: Familial pancreatic cancer (FPC) accounts for approximately 3% of all pancreatic cancer (PC) cases. It has been suggested that high-risk individuals (HRIs) should be offered a screening programme. Aim: To evaluate the diagnostic yield of a prospective screening programme in HRIs from families with FPC over a period of 5 years. Methods: HRIs of families with FPC of the National German Familial Pancreatic Cancer Registry (FaPaCa) were counselled and enrolled in a prospective, board-approved PC screening programme. Screening included clinical examination, laboratory tests, endoscopic ultrasound (EUS) and MRI with magnetic resonance cholangiopancreaticography (MRCP) and MR angiography. Results: Between June 2002 and December 2007, 76 HRIs of families with FPC took part in the screening programme with a total of 182 examination visits. Twenty-eight patients revealed abnormalities in EUS (n = 25) and/or MR/MRCP (n = 12). In 7 patients fine needle aspiration cytology was performed. Operative pancreatic explorations were performed in 7 individuals, resulting in limited resections in 6 cases. Histopathological examination of the resected specimens showed serous oligocystic adenomas (n = 3), pancreatic intraepithelial neoplasia 1 (PanIN1) lesions with lobular fibrosis (n = 1), PanIN2 lesions (n = 1) and PanIN1 lesion plus a gastric type intraductal papillary mucinous neoplasm (IPMN) (n = 1). Conclusions: In FPC an EUS/MR/MRCP-based screening programme leads to the detection of potential precursor lesions of PC. However, the yield of an extensive screening programme is low, especially since the tumourigenic value of low grade PanIN lesions is not yet defined. Taking into account the enormous psychological stress for the tested individual and the high costs, a general PC screening in HRIs is not justified.
- 7 February 2009
- Published by Springer Nature
- p. 271-286
Endokrine Tumoren des Pankreas
- Open Access
- 18 November 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 354
Fast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report
Predictive genetic screening and regular screening programs in patients with multiple endocrine neoplasia type 1 are intended to detect and treat malignant tumors at the earliest stage possible. Malignant neuroendocrine pancreatic tumors are the most frequent cause of death in these patients. However, the extent and intervals of screening in patients with multiple endocrine neoplasia type 1 are controversial as neuroendocrine tumors are usually slow growing. Here we report the case of a patient who developed a fast-growing neuroendocrine carcinoma within 15 months of a laparoscopic distal pancreatic resection. We followed a group of 45 patients with multiple endocrine neoplasia type 1 by an annual screening program in the Department of Visceral, Thoracic, and Vascular Surgery at the University Hospital Marburg in cooperation with the Department of Radiology and the Division of Endocrinology. A man with multiple endocrine neoplasia type 1 who was diagnosed with a recurrent primary hyperparathyroidism underwent a distal pancreatic resection for a non-functional neuroendocrine tumor. In the context of our regular screening program, a large non-functional neuroendocrine tumor was diagnosed in the pancreatic head 15 months after the first pancreatic surgery. Therefore, we performed an enucleation and regional lymph node resection. At histology, the diagnosis of a neuroendocrine carcinoma with one lymph node metastasis was established. There was no evidence of recurrence 9 months after re-operation. Fast-growing neuroendocrine tumors are rare in patients with multiple endocrine neoplasia type 1. The intervals, both postoperative and in newly diagnosed pancreatic lesions, in patients with multiple endocrine neoplasia type 1 should be reduced to 6 months to establish the early diagnosis of rapidly progressive disease in a small subset of patients.
- 18 November 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 354
Open AccessFast-growing pancreatic neuroendocrine carcinoma in a patient with multiple endocrine neoplasia type 1: a case report
Predictive genetic screening and regular screening programs in patients with multiple endocrine neoplasia type 1 are intended to detect and treat malignant tumors at the earliest stage possible. Malignant neuroendocrine pancreatic tumors are the most frequent cause of death in these patients. However, the extent and intervals of screening in patients with multiple endocrine neoplasia type 1 are controversial as neuroendocrine tumors are usually slow growing. Here we report the case of a patient who developed a fast-growing neuroendocrine carcinoma within 15 months of a laparoscopic distal pancreatic resection. We followed a group of 45 patients with multiple endocrine neoplasia type 1 by an annual screening program in the Department of Visceral, Thoracic, and Vascular Surgery at the University Hospital Marburg in cooperation with the Department of Radiology and the Division of Endocrinology. A man with multiple endocrine neoplasia type 1 who was diagnosed with a recurrent primary hyperparathyroidism underwent a distal pancreatic resection for a non-functional neuroendocrine tumor. In the context of our regular screening program, a large non-functional neuroendocrine tumor was diagnosed in the pancreatic head 15 months after the first pancreatic surgery. Therefore, we performed an enucleation and regional lymph node resection. At histology, the diagnosis of a neuroendocrine carcinoma with one lymph node metastasis was established. There was no evidence of recurrence 9 months after re-operation. Fast-growing neuroendocrine tumors are rare in patients with multiple endocrine neoplasia type 1. The intervals, both postoperative and in newly diagnosed pancreatic lesions, in patients with multiple endocrine neoplasia type 1 should be reduced to 6 months to establish the early diagnosis of rapidly progressive disease in a small subset of patients.
- 10 September 2007
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 115 (08) , N5
Multiple endocrine neoplasia type 1 (MEN1) and quality of life
Patients with multiple endocrine neoplasia type 1 (MEN1) represent among cancer patients a particular group of hereditary tumour syndrome with a long duration of disease and multiple follow-ups. MEN1 is characterized by predisposition mainly to tumours of the parathyroid glands and (enteropancreatic) neuroendocrine tumours but also involvement of anterior pituitary, adrenals and other endocrine glands. Only one report regarding quality of life (QoL) in these patients is available so far (Berglund et al., Fam Cancer 2003). Patients and Methods: 23 patients (13 males, 10 females, age range 23–67yrs) with MEN1, followed up by the interdisciplinary team (internists and surgeons) in our university hospital. Patients answered three questionnaires: the Nottingham Health Profile (NHP – a generic healthy survey), the questionnaire for Quality of life – Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA – designed to evaluate adult patients with growth hormone deficiency) and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) Version 3.0– used to asses the health related quality of life in cancer patients (22 patients). The results for the NHP and the EORTC QLQ-C30 were matched to reference data published for theses questionnaires for the German population. Differences ≥ +2 SD (standard deviation) were defined as pathological, ≤+1 as normal and between +1SD and +2 SD as marginal/intermediate. Results: Most pathological scorings in the NHP were for energy lost (26%) and emotional reactions (22%). Only 13% reported pains. 26% of patients showed low QoL as evaluated with the QoL-AGHDA (47% of the studied patients hat pituitary involvement but none of them pituitary hormones deficiencies). Scorings on functional scales of the EORTC QLQ-C30 were comparable and higher for the cognitive and role scales (better QoL), the lowest ratings were achieved for the social, emotional and physical scales. On the symptoms scale more problems were reported with fatigue (41%), less with pain and with nausea/vomiting. The global health/QoL scale reflected only in 14% patients pathological results, but indicated marginal results in 32%. Conclusions: Patients with MEN1 perceives their global/health-related QoL as reduced but still relatively good; items as energy lost/fatigue rises as the most important aspects, probably influencing physical, emotional and social functioning.
- 10 September 2007
- Published by Georg Thieme Verlag KG in Experimental and Clinical Endocrinology & Diabetes
- Vol. 115 (08) , N5
Multiple endocrine neoplasia type 1 (MEN1) and quality of life
Patients with multiple endocrine neoplasia type 1 (MEN1) represent among cancer patients a particular group of hereditary tumour syndrome with a long duration of disease and multiple follow-ups. MEN1 is characterized by predisposition mainly to tumours of the parathyroid glands and (enteropancreatic) neuroendocrine tumours but also involvement of anterior pituitary, adrenals and other endocrine glands. Only one report regarding quality of life (QoL) in these patients is available so far (Berglund et al., Fam Cancer 2003). Patients and Methods: 23 patients (13 males, 10 females, age range 23–67yrs) with MEN1, followed up by the interdisciplinary team (internists and surgeons) in our university hospital. Patients answered three questionnaires: the Nottingham Health Profile (NHP – a generic healthy survey), the questionnaire for Quality of life – Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA – designed to evaluate adult patients with growth hormone deficiency) and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) Version 3.0– used to asses the health related quality of life in cancer patients (22 patients). The results for the NHP and the EORTC QLQ-C30 were matched to reference data published for theses questionnaires for the German population. Differences ≥ +2 SD (standard deviation) were defined as pathological, ≤+1 as normal and between +1SD and +2 SD as marginal/intermediate. Results: Most pathological scorings in the NHP were for energy lost (26%) and emotional reactions (22%). Only 13% reported pains. 26% of patients showed low QoL as evaluated with the QoL-AGHDA (47% of the studied patients hat pituitary involvement but none of them pituitary hormones deficiencies). Scorings on functional scales of the EORTC QLQ-C30 were comparable and higher for the cognitive and role scales (better QoL), the lowest ratings were achieved for the social, emotional and physical scales. On the symptoms scale more problems were reported with fatigue (41%), less with pain and with nausea/vomiting. The global health/QoL scale reflected only in 14% patients pathological results, but indicated marginal results in 32%. Conclusions: Patients with MEN1 perceives their global/health-related QoL as reduced but still relatively good; items as energy lost/fatigue rises as the most important aspects, probably influencing physical, emotional and social functioning.
- 3 March 2005
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 130 (10) , 508-513
Qualität der chirurgischen Weiterbildung in Deutschland
Hintergrund: Ursachen für eine zunehmende Abwanderung junger Ärzte in den nichtkurativen Bereich und ins Ausland sind unter anderem in qualitativ defizitärer Weiterbildung zu suchen. Ziel dieser Studie war eine Evaluation des Ist-Zustandes der chirurgischen Weiterbildung in Deutschland aus der Sicht der Weiterbildungsassistenten. Methoden: Von Assistenten und chirurgischen Weiterbildern der Deutschen Gesellschaft für Chirurgie und des Berufsverbandes der Deutschen Chirurgen (BDC) wurde ein umfangreicher Fragebogen erarbeitet und zwischen Juni 2003 und Juni 2004 an chirurgische Assistenten verschickt, in den Mitteilungen des BDC publiziert sowie auf Facharztseminaren des BDC verteilt. Die Fragebogen konnten anonym an den BDC zurückgesandt oder im Internet beantwortet werden. Ergebnisse: Die Rücklaufquote der Umfrage (n = 584) wurde auf 30 % geschätzt. 58 % der chirurgischen Assistenten gaben an, die Facharztreife in der Regelzeit von 6 Jahren zu erreichen. Eine Struktur für die Weiterbildung, z. B. ein Rotationsprogramm, gab es nur bei 43 % der Umfrageteilnehmer. Standard-Operationen wurden vor dem Eingriff bei 46 % der Teilnehmer erklärt. 61 % der jungen Chirurgen waren mit den Lehrassistenzen durch Weiterbilder unzufrieden, wobei die Unzufriedenheit in Universitätskliniken mit 77 % am größten war. . Nur bei 33 % der Umfrageteilnehmer fanden regelmäßig Weiterbildungsgespräche statt. 18 % gaben an, dass sich ihr Arbeitgeber für die Weiterbildung seiner Mitarbeiter interessiert. Tägliche Indikationskonferenzen fanden nur bei 52 % statt, regelmäßige Mortalitäts- und Morbiditätskonferenzen lediglich bei 20 %. Fortbildungsveranstaltungen innerhalb der Klinik fanden bei 62 % der Umfrageteilnehmer statt. 61 % erhielten für den Besuch externer Seminare oder Kongresse keine finanzielle Unterstützung, und 36 % mussten dafür zusätzlich Erholungsurlaub einreichen. Schlussfolgerungen: In mindestens 50 % der Kliniken, aus denen uns Antworten erreichten, existieren unzureichende Weiterbildungsstrukturen. Eine dringliche gemeinsame Aufgabe ist die Entwicklung von Empfehlungen zur Gestaltung und Strukturierung der chirurgischen Weiterbildung, die Einführung von Logbüchern und die Nutzung von Feedback- und Rotationsprogrammen. Background: One of the reasons for young doctors to leave the clinical work to go abroad or into non-clinical fields is insufficient quality of training under bad circumstances. Aim of the study was to evaluate the surgical training in Germany from the viewpoint of the residents. Methods: A questionnaire was prepared by residents and consultants and approved by the German surgical societies (Deutsche Gesellschaft für Chirurgie und Berufsverband der Deutschen Chirurgen). It was sent to surgical residents between June 2003 and June 2004, published in „Der Chirurg BDC” and distributed among residents taking part in courses conducted by the BDC. It could be answered anonymously by email, mail or online. Results: The questionnaire was sent back by 584 surgical residents (about 30 % of all). 58 % of the residents declared that they finished the training in the intended time (6 years). Rotation-systems as part of a structured residency program existed for 43 %. Standard surgical procedures were discussed or explained before the procedure in only 46 %. 61 % of the residents were not satisfied with the teaching assistance by their clinical teachers in the OR. Only 33 % had regular talks with the Chief about their progress in surgical training. 18 % of residents felt, that the hospital is interested in their progress in training. Indication-conferences took place in 52 % and mortality-conferences in only 20 % of programs. Regular seminars on recent issues took place in 62 %, and 61 % of residents did not get financial support to attend congresses. 36 % of residents had to use their holidays to attend congresses. Conclusions: Surgical training structures are not well established in about 50 % of the training hospitals from where we got answers to our survey. The training potential of daily surgical work is not used appropriately. It is therefore imperative to develop guidelines for surgical training, the use of log-books and rotation-programs.
- 3 March 2005
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 130 (10) , 508-513
Qualität der chirurgischen Weiterbildung in Deutschland
Hintergrund: Ursachen für eine zunehmende Abwanderung junger Ärzte in den nichtkurativen Bereich und ins Ausland sind unter anderem in qualitativ defizitärer Weiterbildung zu suchen. Ziel dieser Studie war eine Evaluation des Ist-Zustandes der chirurgischen Weiterbildung in Deutschland aus der Sicht der Weiterbildungsassistenten. Methoden: Von Assistenten und chirurgischen Weiterbildern der Deutschen Gesellschaft für Chirurgie und des Berufsverbandes der Deutschen Chirurgen (BDC) wurde ein umfangreicher Fragebogen erarbeitet und zwischen Juni 2003 und Juni 2004 an chirurgische Assistenten verschickt, in den Mitteilungen des BDC publiziert sowie auf Facharztseminaren des BDC verteilt. Die Fragebogen konnten anonym an den BDC zurückgesandt oder im Internet beantwortet werden. Ergebnisse: Die Rücklaufquote der Umfrage (n = 584) wurde auf 30 % geschätzt. 58 % der chirurgischen Assistenten gaben an, die Facharztreife in der Regelzeit von 6 Jahren zu erreichen. Eine Struktur für die Weiterbildung, z. B. ein Rotationsprogramm, gab es nur bei 43 % der Umfrageteilnehmer. Standard-Operationen wurden vor dem Eingriff bei 46 % der Teilnehmer erklärt. 61 % der jungen Chirurgen waren mit den Lehrassistenzen durch Weiterbilder unzufrieden, wobei die Unzufriedenheit in Universitätskliniken mit 77 % am größten war. . Nur bei 33 % der Umfrageteilnehmer fanden regelmäßig Weiterbildungsgespräche statt. 18 % gaben an, dass sich ihr Arbeitgeber für die Weiterbildung seiner Mitarbeiter interessiert. Tägliche Indikationskonferenzen fanden nur bei 52 % statt, regelmäßige Mortalitäts- und Morbiditätskonferenzen lediglich bei 20 %. Fortbildungsveranstaltungen innerhalb der Klinik fanden bei 62 % der Umfrageteilnehmer statt. 61 % erhielten für den Besuch externer Seminare oder Kongresse keine finanzielle Unterstützung, und 36 % mussten dafür zusätzlich Erholungsurlaub einreichen. Schlussfolgerungen: In mindestens 50 % der Kliniken, aus denen uns Antworten erreichten, existieren unzureichende Weiterbildungsstrukturen. Eine dringliche gemeinsame Aufgabe ist die Entwicklung von Empfehlungen zur Gestaltung und Strukturierung der chirurgischen Weiterbildung, die Einführung von Logbüchern und die Nutzung von Feedback- und Rotationsprogrammen. Background: One of the reasons for young doctors to leave the clinical work to go abroad or into non-clinical fields is insufficient quality of training under bad circumstances. Aim of the study was to evaluate the surgical training in Germany from the viewpoint of the residents. Methods: A questionnaire was prepared by residents and consultants and approved by the German surgical societies (Deutsche Gesellschaft für Chirurgie und Berufsverband der Deutschen Chirurgen). It was sent to surgical residents between June 2003 and June 2004, published in „Der Chirurg BDC” and distributed among residents taking part in courses conducted by the BDC. It could be answered anonymously by email, mail or online. Results: The questionnaire was sent back by 584 surgical residents (about 30 % of all). 58 % of the residents declared that they finished the training in the intended time (6 years). Rotation-systems as part of a structured residency program existed for 43 %. Standard surgical procedures were discussed or explained before the procedure in only 46 %. 61 % of the residents were not satisfied with the teaching assistance by their clinical teachers in the OR. Only 33 % had regular talks with the Chief about their progress in surgical training. 18 % of residents felt, that the hospital is interested in their progress in training. Indication-conferences took place in 52 % and mortality-conferences in only 20 % of programs. Regular seminars on recent issues took place in 62 %, and 61 % of residents did not get financial support to attend congresses. 36 % of residents had to use their holidays to attend congresses. Conclusions: Surgical training structures are not well established in about 50 % of the training hospitals from where we got answers to our survey. The training potential of daily surgical work is not used appropriately. It is therefore imperative to develop guidelines for surgical training, the use of log-books and rotation-programs.
- 1 June 2004
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 36 (06) , 23
The German Adrenocortical Carcinoma (ACC) Registry – Establishment and First Results
ACC is a rare tumor with poor prognosis. Its low incidence hinders the development of a reliable database on clinical manifestations, prognosis, and the impact of different treatment options. The purpose of the German ACC Registry is to evaluate these aspects in a large retrospective series and to establish a prospective database to improve patient care and recruitment for future clinical trials. In June 2003, a structured evaluation form collecting comprehensive information on diagnostic procedures, therapy, and follow-up was developed. All GANIMED (German Adrenal Network: Improving Medical research and Education) centers and the Study Group for Malignant Endocrine Tumors in Childhood were contacted to include patients (diagnosed after 1982) in this registry. A website (http:www.nebennierenkarzinom.de) was created containing all the information required for patient enrolment. Ninety-five patients (females 63%; males 37%) were included in the registry until January 2004. The mean age at diagnosis was 39 years (range 0.3–83 years). Hormone excess was detectable in 55% of the patients. Three patients were diagnosed as stage I (< 5 cm), 32 as stage II (> 5 cm), 33 as stage III (advanced locoregional disease), and 27 as stage IV (metastasized disease) at the time of primary diagnosis. Mean tumor size at diagnosis was 11 ± 4 cm (3–21cm). Surgery was performed in all patients. Metastases occurred mainly in lung (47%), liver (30%), and bone (13%). The median survival of all patients was 33 (1–274) months. As expected, the survival differed significantly according to the stage. Enrolment into the retrospective registry will be open until December 2004. This registry will allow a detailed analysis of prognostic factors and the present outcome in patients with ACC in Germany. The prospective registry will only include newly diagnosed patients with ACC. Its aims will include improvement in patient care and participation in international therapeutic trials such as the proposed First International Randomized trial in Metastastic Adrenocortical Cancer Treatment (FIRM-ACT).
- 1 June 2004
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 36 (06) , 23
The German Adrenocortical Carcinoma (ACC) Registry – Establishment and First Results
ACC is a rare tumor with poor prognosis. Its low incidence hinders the development of a reliable database on clinical manifestations, prognosis, and the impact of different treatment options. The purpose of the German ACC Registry is to evaluate these aspects in a large retrospective series and to establish a prospective database to improve patient care and recruitment for future clinical trials. In June 2003, a structured evaluation form collecting comprehensive information on diagnostic procedures, therapy, and follow-up was developed. All GANIMED (German Adrenal Network: Improving Medical research and Education) centers and the Study Group for Malignant Endocrine Tumors in Childhood were contacted to include patients (diagnosed after 1982) in this registry. A website (http:www.nebennierenkarzinom.de) was created containing all the information required for patient enrolment. Ninety-five patients (females 63%; males 37%) were included in the registry until January 2004. The mean age at diagnosis was 39 years (range 0.3–83 years). Hormone excess was detectable in 55% of the patients. Three patients were diagnosed as stage I (< 5 cm), 32 as stage II (> 5 cm), 33 as stage III (advanced locoregional disease), and 27 as stage IV (metastasized disease) at the time of primary diagnosis. Mean tumor size at diagnosis was 11 ± 4 cm (3–21cm). Surgery was performed in all patients. Metastases occurred mainly in lung (47%), liver (30%), and bone (13%). The median survival of all patients was 33 (1–274) months. As expected, the survival differed significantly according to the stage. Enrolment into the retrospective registry will be open until December 2004. This registry will allow a detailed analysis of prognostic factors and the present outcome in patients with ACC in Germany. The prospective registry will only include newly diagnosed patients with ACC. Its aims will include improvement in patient care and participation in international therapeutic trials such as the proposed First International Randomized trial in Metastastic Adrenocortical Cancer Treatment (FIRM-ACT).
- 1 April 2004
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 129 (17) , 941-946
Diagnostik und operative Therapie beim Insulinom - Erfahrungen bei 40 Patienten
Hintergrund und Fragestellung: Insulinome sind überwiegend benigne solitäre und funktionelle neuroendokrine Pankreastumoren. Die Symptome sind vielfältig, die präoperative Lokalisationsdiagnostik häufig wenig sensitiv und die Heilungsrate durch operative Tumorentfernung sehr gut. Ziel der Studie war die Analyse, Evaluierung des eigenen Krankengutes bezüglich der präoperativen Lokalisationsdiagnostik und der Operationsergebnisse. Methoden: Die Daten aller Patienten, die an der Klinik für Visceral-, Thorax- und Gefäßchirurgie der Philipps-Universität Marburg zwischen 1987 und 2003 wegen eines Insulinoms behandelt wurden, wurden im Rahmen einer prospektiven Beobachtungsstudie erfasst und retrospektiv ausgewertet. Die Verdachtsdiagnose wurde bei allen Patienten durch einen Hungerversuch bestätigt. Ergebnisse: Im Beobachtungszeitraum wurden 40 Patienten (22 Frauen, 18 Männer) mit einem mittleren Alter von 52 Jahren (Spannbreite 12-87 Jahre) wegen eines Insulinoms operiert. In der präoperativen Lokalisationsdiagnostik betrugen die Sensitivitäten von Endosonographie (EUS), Sonographie (US), Computertomographie (CT), Kernspintomographie (MRT) und Somatostatin-Rezeptor-Szintigraphie (SRS) 65 %, 33 %, 33 %, 15 % und 0 %. Im Gegensatz dazu, konnten alle Insulinome intraoperativ durch Pankreasfreilegung und intraoperative Ultrasonographie (IOUS) identifiziert werden. 5 Patienten wurden wegen eines malignen Insulinoms operiert. 38 Patienten konnten durch die operative Entfernung des Tumors dauerhaft geheilt werden. Schlussfolgerung: Nach biochemischer Sicherung des Insulinoms durch einen adäquaten Hungerversuch und Ausschluss einer diffusen abdominellen Metastasierung durch transabdominellen Ultraschall, sollte der Patient ohne weitere präoperative Lokalisationsdiagnostik der Operation mit IOUS und bidigitaler Pankreaspalpation zugeführt werden. Eine Ausnahme besteht bei einer laparoskopisch geplanten Operation, dort sollte präoperativ zusätzlich eine Endosonographie durchgeführt werden. Background and objective: Most insulinomas are solitary, benign and functional neuroendocrine pancreatic tumors which give rise to manifold symptoms. Their preoperative localization is often unclear, but the cure rate after their excision is very high. It was the aim of this study to analyse and evaluate our group of patients with regard to preoperative tumor localization and overall surgical results. Methods: Data were collected as part of prospective observations and retrospective evaluation of all patients treated for insulinoma between 1987 and 2003 at the department of visceral- thoracic- and vascular surgery at the Philipps University of Marburg. In all of them the diagnosis had been confirmed by a fasting test. Results: 40 patients with an insulinoma (22 females, 18 males; average age 52 years [range 12-87 years]) had been operated. The sensitivity of preoperative localization was 65% for endoscopic ultrasound, 33% for ultrasound, 33% for computed tomography, 15% for magnetic resonance imaging and 0% for somatostatin-receptor scintigraphy. But all insulinomas were identified intraoperatively by pancreas dissection and ultrasound (IOUS). 38 patients were completely cured by excision of the tumor. Conclusion: After positive biochemical and fasting tests and exclusion of diffuse abdominal metastases by transabdominal ultrasound, all patients should without further preoperative investigations undergo surgical excision of the insulinoma after bidigital palpation of the pancreas and IOUS. But if laparoscopic excision is planned, endoscopic ultrasound should be undertaken preoperatively.
- 1 April 2004
- Published by Georg Thieme Verlag KG in DMW - Deutsche Medizinische Wochenschrift
- Vol. 129 (17) , 941-946
Diagnostik und operative Therapie beim Insulinom - Erfahrungen bei 40 Patienten
Hintergrund und Fragestellung: Insulinome sind überwiegend benigne solitäre und funktionelle neuroendokrine Pankreastumoren. Die Symptome sind vielfältig, die präoperative Lokalisationsdiagnostik häufig wenig sensitiv und die Heilungsrate durch operative Tumorentfernung sehr gut. Ziel der Studie war die Analyse, Evaluierung des eigenen Krankengutes bezüglich der präoperativen Lokalisationsdiagnostik und der Operationsergebnisse. Methoden: Die Daten aller Patienten, die an der Klinik für Visceral-, Thorax- und Gefäßchirurgie der Philipps-Universität Marburg zwischen 1987 und 2003 wegen eines Insulinoms behandelt wurden, wurden im Rahmen einer prospektiven Beobachtungsstudie erfasst und retrospektiv ausgewertet. Die Verdachtsdiagnose wurde bei allen Patienten durch einen Hungerversuch bestätigt. Ergebnisse: Im Beobachtungszeitraum wurden 40 Patienten (22 Frauen, 18 Männer) mit einem mittleren Alter von 52 Jahren (Spannbreite 12-87 Jahre) wegen eines Insulinoms operiert. In der präoperativen Lokalisationsdiagnostik betrugen die Sensitivitäten von Endosonographie (EUS), Sonographie (US), Computertomographie (CT), Kernspintomographie (MRT) und Somatostatin-Rezeptor-Szintigraphie (SRS) 65 %, 33 %, 33 %, 15 % und 0 %. Im Gegensatz dazu, konnten alle Insulinome intraoperativ durch Pankreasfreilegung und intraoperative Ultrasonographie (IOUS) identifiziert werden. 5 Patienten wurden wegen eines malignen Insulinoms operiert. 38 Patienten konnten durch die operative Entfernung des Tumors dauerhaft geheilt werden. Schlussfolgerung: Nach biochemischer Sicherung des Insulinoms durch einen adäquaten Hungerversuch und Ausschluss einer diffusen abdominellen Metastasierung durch transabdominellen Ultraschall, sollte der Patient ohne weitere präoperative Lokalisationsdiagnostik der Operation mit IOUS und bidigitaler Pankreaspalpation zugeführt werden. Eine Ausnahme besteht bei einer laparoskopisch geplanten Operation, dort sollte präoperativ zusätzlich eine Endosonographie durchgeführt werden. Background and objective: Most insulinomas are solitary, benign and functional neuroendocrine pancreatic tumors which give rise to manifold symptoms. Their preoperative localization is often unclear, but the cure rate after their excision is very high. It was the aim of this study to analyse and evaluate our group of patients with regard to preoperative tumor localization and overall surgical results. Methods: Data were collected as part of prospective observations and retrospective evaluation of all patients treated for insulinoma between 1987 and 2003 at the department of visceral- thoracic- and vascular surgery at the Philipps University of Marburg. In all of them the diagnosis had been confirmed by a fasting test. Results: 40 patients with an insulinoma (22 females, 18 males; average age 52 years [range 12-87 years]) had been operated. The sensitivity of preoperative localization was 65% for endoscopic ultrasound, 33% for ultrasound, 33% for computed tomography, 15% for magnetic resonance imaging and 0% for somatostatin-receptor scintigraphy. But all insulinomas were identified intraoperatively by pancreas dissection and ultrasound (IOUS). 38 patients were completely cured by excision of the tumor. Conclusion: After positive biochemical and fasting tests and exclusion of diffuse abdominal metastases by transabdominal ultrasound, all patients should without further preoperative investigations undergo surgical excision of the insulinoma after bidigital palpation of the pancreas and IOUS. But if laparoscopic excision is planned, endoscopic ultrasound should be undertaken preoperatively.